Liu, C., Sun, H., Huang, W., Wang, Z., Fu, C., Han, D., . . . Li, B. (2023). Sintilimab as maintenance treatment for local/regional recurrent esophageal squamous carcinoma after concurrent chemoradiotherapy. Frontiers in Immunology, 14, . https://doi.org/10.3389/fimmu.2023.1193394
Chicago-referens (17:e uppl.)Liu, Chengxin, Hongfu Sun, Wei Huang, Zhongtang Wang, Chengrui Fu, Dan Han, Qian Zhao, Xue Wu, och Baosheng Li. "Sintilimab as Maintenance Treatment for Local/regional Recurrent Esophageal Squamous Carcinoma After Concurrent Chemoradiotherapy." Frontiers in Immunology 14 (2023). https://doi.org/10.3389/fimmu.2023.1193394.
MLA-referens (9:e uppl.)Liu, Chengxin, et al. "Sintilimab as Maintenance Treatment for Local/regional Recurrent Esophageal Squamous Carcinoma After Concurrent Chemoradiotherapy." Frontiers in Immunology, vol. 14, 2023, https://doi.org/10.3389/fimmu.2023.1193394.
